...
首页> 外文期刊>Korean Circulation Journal >Effect of the Long-Term Therapy with Felodipine(Munobal?) in Patients with Essential Hypertension : With Reference to Persistence of Its Antihypertensive Effect and Safety
【24h】

Effect of the Long-Term Therapy with Felodipine(Munobal?) in Patients with Essential Hypertension : With Reference to Persistence of Its Antihypertensive Effect and Safety

机译:长期使用非洛地平(孟买吗?)对原发性高血压患者的疗效:参考其持续降压作用和安全性

获取原文
           

摘要

Background Hypertension is a major and growing public health problem and it calls for life-long management. The antihypertensive agents are still playing major roles in the management of hypertension. We studied the effect of the long-term therapy with a new calcium channel blocker, felodipine in patients with essential hypertension. Methods We recruited 31 patients with mild to moderate essential hypertention and gave them 5mg (1 tablet) of felodipine(Munobal?) once daily for 12 months. We measured the blood pressure and the heart rate every month and tried to detect any untoward symptoms and signs during the whole observation period. Baseline work-up for the hypertensive patients were done as usual before and after the study. Results The average systolic and diastolic blood pressures were 162.7±9.7/99.6±7.4mmHg respectively before the administration and they came down to the level of 139.7±15.0/87.3±8.6mmHg respectively at the end of the 1st month (p Conclusion Felodipine has good and persistent hypotensive effect and it is safe and easy to use.
机译:背景技术高血压是一个日益严重的主要公共卫生问题,需要终生管理。抗高血压药在高血压的治疗中仍起着主要作用。我们研究了使用新型钙通道阻滞剂非洛地平的长期治疗对原发性高血压患者的疗效。方法我们招募了31名轻度至中度原发性高血压患者,并给予他们5mg(1片)非洛地平(Munobal?)每天一次,持续12个月。我们每月测量一次血压和心率,并试图在整个观察期内发现任何不适的症状和体征。在研究之前和之后,照常对高血压患者进行基线检查。结果给药前的平均收缩压和舒张压分别为162.7±9.7 / 99.6±7.4mmHg,在第一个月月末分别降至139.7±15.0 / 87.3±8.6mmHg(p结论非洛地平具有良好而持久的降压作用,安全且易于使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号